Artivion (AORT) Cash & Current Investments (2009 - 2026)
Artivion (AORT) reported Cash & Current Investments of $55.8 million for Q1 2026, up 47.94% on a YoY basis from $37.7 million in Q1 2025, and down 14.09% quarter-over-quarter from $64.9 million in Q4 2025.
Artivion (AORT) Cash & Current Investments (2009 - 2026) Analysis & Trends
Artivion has reported Cash & Current Investments for 18 years, with the latest figure at $55.8 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 47.94% year-over-year to $55.8 million; the trailing twelve-month figure through Mar 2026 stood at $55.8 million (up 47.94% YoY), and the FY2025 full-year result was $64.9 million, up 21.41% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $55.8 million, down from $64.9 million in the prior quarter.
- The five-year high for Cash & Current Investments was $73.4 million in Q3 2025, with the low at $10.1 million in Q3 2022.
- Historically, Cash & Current Investments has averaged $49.1 million across 5 years, with a median of $53.5 million in 2024.
- Annual changes were most pronounced in 2022 — Cash & Current Investments sank 84.57% — and 2023, when it surged 432.1%.
- Artivion's Cash & Current Investments stood at $39.4 million in 2022, then soared by 49.78% to $58.9 million in 2023, then fell by 9.29% to $53.5 million in 2024, then rose by 21.41% to $64.9 million in 2025, then retreated by 14.09% to $55.8 million in 2026.
- The last three Cash & Current Investments figures came in at $55.8 million (Q1 2026), $64.9 million (Q4 2025), and $73.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Artivion | 1.02 Bn | 961.48 Mn | 75.45 Mn | 55.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.76 Mn |
| Dec 31, 2025 | 64.91 Mn |
| Sep 30, 2025 | 73.43 Mn |
| Jun 30, 2025 | 53.48 Mn |
| Mar 31, 2025 | 37.69 Mn |
| Dec 31, 2024 | 53.46 Mn |
| Sep 30, 2024 | 56.17 Mn |
| Jun 30, 2024 | 55.02 Mn |
| Mar 31, 2024 | 51.12 Mn |
| Dec 31, 2023 | 58.94 Mn |
| Sep 30, 2023 | 53.48 Mn |
| Jun 30, 2023 | 48.78 Mn |
| Mar 31, 2023 | 30.77 Mn |
| Dec 31, 2022 | 39.35 Mn |
| Sep 30, 2022 | 10.05 Mn |
| Jun 30, 2022 | 40.38 Mn |
| Mar 31, 2022 | 51.41 Mn |
| Dec 31, 2021 | 55.01 Mn |
| Sep 30, 2021 | 65.13 Mn |
| Jun 30, 2021 | 51.03 Mn |